🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More

Published 23/06/2022, 09:25
© Reuters.  76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
IXIC
-
OBCI
-
ATHA
-

Gainers

  • Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
  • Phoenix Motor Inc. (NASDAQ: PEV) jumped 70.5% to close at $5.83.
  • Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) gained 47.9% to close at $1.73.
  • Exela Technologies, Inc. (NASDAQ: XELA) gained 39.2% to close at $0.1897 after the company announced a new customer win of $136 million in total contract value.
  • U.S. Well Services, Inc. (NASDAQ: USWS) climbed 37.3% to close at $0.9872 after ProFrac Holding announced plans to acquire the company for $1.21 per share in an all-stock deal.
  • Regis Corporation (NYSE: RGS) shares climbed 36.4% to settle at $0.90 on above-average volume.
  • Vaccitech plc (NASDAQ: VACC) gained 35.6% to close at $6.21. Vaccitech announced an update to the interim analysis of safety and efficacy data from the HBV002 study evaluating ChAdOx1-HBV and MVA-HBV vaccines (VTP-300) in chronic HBV patients who are virally suppressed with oral anti-viral therapies.
  • Boxed, Inc. (NYSE: BOXD) climbed 35.4% to close at $2.18.
  • Silence Therapeutics plc (NASDAQ: SLN) surged 34.8% to settle at $11.75.
  • Omeros Corporation (NASDAQ: OMER) gained 34.7% to settle at $2.95.
  • Revlon, Inc. (NYSE: REV) climbed 34.3% to close at $8.14 on continued volatility following the company's recent bankruptcy filing. The stock has also been circulated as a short squeeze candidate.
  • Angion Biomedica Corp. (NASDAQ: ANGN) gained 31.2% to close at $2.02.
  • Accelerate Diagnostics, Inc. (NASDAQ: AXDX) rose 28.2% to close at $1.12.
  • Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) surged 27.3% to close at $3.40. Anebulo Pharmaceuticals, last month, posted a Q3 loss of $0.08 per share.
  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) jumped 24.7% to settle at $34.18.
  • Kirkland's, Inc. (NASDAQ: KIRK) rose 23.8% to close at $4.69. The Kirkland Company announced the sale of Amaze @ NoDa.
  • Better Therapeutics, Inc. (NASDAQ: BTTX) surged 23.5% to close at $1.84.
  • MSP Recovery, Inc. (NASDAQ: MSPR) jumped 21.9% to settle at $1.89.
  • BioSig Technologies, Inc. (NASDAQ: BSGM) rose 21.3% to close at $0.88 after the company announced it entered an evaluation agreement for its PURE EP System with the Cleveland Clinic.
  • cbdMD, Inc. (NYSE: YCBD) gained 21.3% to close at $0.5166 in reaction to a report MLB teams can now be sponsored by CBD companies.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) gained 21.2% to close at $0.7520 on abnormally-high volume.
  • 22nd Century Group, Inc. (NASDAQ: XXII) surged 20.3% to close at $1.96. The FDA has cleared Juul rivals to keep tobacco-flavored e-cigarettes on the market, according to Dow Jones.
  • NanoVibronix, Inc. (NASDAQ: NAOV) rose 20.3% to settle at $0.7347.
  • G. Willi-Food International Ltd. (NASDAQ: WILC) gained 19.1% to settle at $16.50.
  • Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) gained 19% to close at $0.4224.
  • Oncorus, Inc. (NASDAQ: ONCR) rose 18.1% to settle at $1.50. Chardan Capital recently initiated coverage on Oncorus with a Buy rating and announced a price target of $5.
  • Cytosorbents Corporation (NASDAQ: CTSO) jumped 17.6% to close at $2.07.
  • Mercurity Fintech Holding Inc. (NASDAQ: MFH) gained 17.1% to settle at $0.9599.
  • JX Luxventure Limited (NASDAQ: LLL) rose 16.8% to close at $1.74. JX Luxventure announced a $5 million buyback and also signed a $30 million sales agreement.
  • CymaBay Therapeutics, Inc. (NASDAQ: CBAY) gained 16.5% to close at $2.40.
  • DURECT Corporation (NASDAQ: DRRX) rose 16.5% to close at $0.5267.
  • Vor Biopharma Inc. (NASDAQ: VOR) jumped 16.3% to close at $5.27.
  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) gained 15.7% to settle at $1.40.
  • Green Giant Inc. (NASDAQ: GGE) gained 15.7% to close at $1.40.
  • Medicenna Therapeutics Corp. (NASDAQ: MDNA) jumped 15.3% to close at $0.9755 after reporting fiscal year 2022 results.
  • Uxin Limited (NASDAQ: UXIN) rose 14.9% to settle at $0.5091.
  • AutoWeb, Inc. (NASDAQ: AUTO) gained 14.7% to close at $0.3772.
  • Ideanomics, Inc. (NASDAQ: IDEX) rose 14.4% to close at $0.7822.
  • Quotient Limited (NASDAQ: QTNT) rose 14.3% to close at $0.4270. Quotient said it expects to report reagent business generated product sales of $9.8 million in the fourth quarter of Fiscal 2022. The company also sees FY22 revenue of $38.5 million.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) climbed 13.5% to close at $0.7666. RedHill Biopharma was granted U.S. Patent #11,364,227 Sphingosine kinase 2 inhibitor for treating coronavirus infection.
  • Wave Life Sciences Ltd. (NASDAQ: WVE) shares gained 11.7% to close at $2.30. Wave Life Sciences recently announced pricing of $70.0 million underwritten offering.
  • F-star Therapeutics, Inc. (NASDAQ: FSTX) jumped 11.2% to close at $3.98.
  • Worksport Ltd. (NASDAQ: WKSP) jumped 10.7% to close at $2.07 after the company launched storefronts on Amazon (NASDAQ:AMZN), eBay (NASDAQ:EBAY) and Walmart (NYSE:WMT) Marketplace.
  • Invitae Corporation (NYSE: NVTA) climbed 9.3% to close at $2.47.
  • Epizyme, Inc. (NASDAQ: EPZM) gained 8.6% to close at $0.8632.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) rose 8.2% to close at $2.25.
  • La-Z-Boy Incorporated (NYSE: LZB) rose 7.9% to settle at $24.52 after the company reported upbeat results for its fourth quarter and issued strong sales forecast for the first quarter.
  • Precision BioSciences, Inc. (NASDAQ: DTIL) shares rose 7.2% to close at $1.49 as the company reported a $50 million offering of common stock and announced in vivo gene editing collaboration with Novartis to develop potentially curative treatment for disorders including sickle cell disease.
  • TScan Therapeutics, Inc. (NASDAQ: TCRX) rose 5.3% to close at $2.99.

Losers

  • Athira Pharma, Inc. (NASDAQ: ATHA) shares dipped 66.3% to close at $2.85 on Wednesday after the company reported that the primary endpoint of change in biomarker ERP P300 latency was not statistically significant from its exploratory ACT-AD Phase 2 study of fosgonimeton.
  • Alexco Resource Corp. (NYSE: AXU) fell 40.7% to close at $0.4801.
  • Neptune Wellness Solutions Inc. (NASDAQ: NEPT) declined 40.7% to settle at $1.72 after the company announced a $5 million registered direct offering.
  • Electric Last Mile Solutions, Inc. (NASDAQ: ELMS) declined 35% to close at $0.1884.
  • SOS Limited (NYSE: SOS) fell 26.7% to close at $0.22 after the company announced an ADS ratio change from 1 ADS representing 10 ordinary shares to 1 ADS representing 500 ordinary shares.
  • Zynex, Inc. (NASDAQ: ZYXI) dropped 22% to settle at $6.92. Zynex recently announced an additional $10 million share buyback program.
  • Regencell Bioscience Holdings Limited (NASDAQ: RGC) dipped 20.3% to close at $32.52.
  • Usio, Inc. (NASDAQ: USIO) fell 19.7% to close at $2.28.
  • Transphorm, Inc. (NASDAQ: TGAN) dropped 19.4% to close at $5.50. B. Riley Securities recently downgraded Transphorm from Buy to Neutral and lowered the price target from $9 to $6.5.
  • CEA Industries Inc. (NASDAQ: CEAD) fell 19.2% to close at $1.14. CEA Industries’ subsidiary, Surna Cultivation Technologies, announced it secured a letter of intent from Greene Brothers Farm for a potential $10 million in revenues.
  • SpringBig Holdings, Inc. (NASDAQ: SBIG) fell 18.8% to close at $2.51. springbig recently completed its merger with Tuatara Capital.
  • Tellurian Inc. (NASDAQ: TELL) declined 17.4% to close at $3.04.
  • Sidus Space, Inc. (NASDAQ: SIDU) fell 17.3% to close at $4.50.
  • ADS-TEC Energy PLC (NASDAQ: ADSE) fell 17% to close at $4.93.
  • Micro Focus International (LON:MCRO) plc (NYSE: MFGP) fell 16% to close at $3.62.
  • Home Point Capital Inc. (NASDAQ: HMPT) dropped 14.7% to settle at $3.48.
  • G Medical Innovations Holdings Ltd (NASDAQ: GMVD) declined 14.6% to close at $0.82.
  • Mereo BioPharma Group plc (NASDAQ: MREO) dipped 14.2% to close at $1.45.
  • Fresh Vine Wine, Inc. (NYSE: VINE) fell 13.6% to close at $1.8999.
  • Redbox Entertainment Inc. (NASDAQ: RDBX) fell 12.9% to close at $10.10.
  • Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) declined 12.2% to close at $1.73. Kaival Brands recently reached an agreement with Phillip Morris for international electronic nicotine delivery system product distribution.
  • 4D pharma plc (NASDAQ: LBPS) declined 11.4% to close at $1.56.
  • BioRestorative Therapies, Inc. (NASDAQ: BRTX) dropped 11.3% to close at $3.23. BioRestorative Therapies selected the Center for Clinical Research in North Carolina as the company's second contract for its Phase 2 trial targeting chronic lumbar disc disease (cLDD).
  • Centennial Resource Development, Inc. (NASDAQ: CDEV) fell 11.2% to close at $6.60.
  • ProFrac Holding Corp. (NASDAQ: PFHC) declined 10.1% to close at $19.31. ProFrac Holding announced plans to acquire U.S. Well Services for $1.21 per share in an all-stock deal.
  • Borr Drilling Limited (NYSE: BORR) shares fell 8.9% to close at $5.55 following a 10% surge on Tuesday.
  • AgEagle Aerial Systems, Inc. (NYSE: UAVS) fell 8.4% to close at $0.7057. AgEagle Aerial Systems shares jumped 33% on Tuesday after the company announced the European Union Aviation Safety Agency issued a Design Verification Report (DVR) establishing that the eBee X meets Ground Risk Class M2 mitigation qualifications.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.